
We report our 6 months of experience with zzso zzso in 25 patients with zzso focal zzso zzso characteristics of our patients were similar to those of the populations in the three clinical trials that evaluated zzso for zzso focal zzso One patient experienced sustained seizure freedom for 5 zzso two more patients had zzso periods of seizure freedom of 1 and 4 zzso A total of eight patients zzso reported a greater than 50% reduction in seizure zzso Thirteen patients zzso reported side effects during the zzso mostly zzso fatigue, zzso and gait zzso In five patients zzso these disappeared during the maintenance phase and/or with dose zzso Two patients lost more than zzso of their body zzso Otherwise, in terms of efficacy and adverse effects, our data mirror the profile of zzso described in the three clinical zzso zzso weight loss may occur in individual zzso 

